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To the Editor,
Beta-thalassemia  (β-thal)  is  one  of  the  most 
common autosomal recessive single gene disorders 
worldwide [1]. At least 200 different mutations in 
the β-globin gene that result in the β-thal minor and 
major phenotypes have been described [2,3]. The 
incidence of β-thal is high in Mediterranean regions, 
Iran, India, The Arabian Peninsula, Southeast Asia, 
and  Turkey  [4].  β-thal  is  characterized  by  point 
mutations, small deletions, or insertions that result 
in a decrease in or lack of expression of the β-globin 
chain, and each ethnic group or population has its 
own set of common mutations. In Turkey β-thal is 
common and 12 mutations accounted for 83.3% of 
1500 unrelated cases with homozygous β-thal [5]; 
the remaining mutations were rare or newly identi-
fied. To date, at least 39 nucleotide insertions in 3 
exons of the β-globin gene that result in a modified 
C-terminal sequence of the β-globin protein have 
been  reported  (http://globin.bx.psu.edu/cgi-bin/
hbvar/query_vars3).  Codon  9/10  (+T)  insertion 
mutation was first described in a Greek family by 
Wave et al. in 1994 [6], followed by the report of an 
Iranian patient of Kurdish origin by Rahimi et al [7]. 
Herein we present a 30-year-old Arab male with the 
β-thal trait living in Hatay, Turkey that had β-globin 
gene codon 9/10 (+T) frameshift mutation, which 
was noted during premarital genetic screening. To 
the  best  of  our  knowledge  this  is  the  first  case 
reported from Turkey and only the third case world-
wide. 
In our laboratory where molecular testing for the 
premarital screening of thalassemia mutations are 
routinely performed, we encountered a case of a 30 
year-old  male  meeting  the  diagnostic  criteria  of 
β-thal  trait.  After  written  informed  consent,  the 
patient accepted to undergo mutation analysis and 
laboratory tests.
Genetic analysis showed a frameshift mutation-
an insertion of T between codons 9 and 10 in the 
first exon of the β-globin gene. Hematological data 
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routine  methodology.  Red  cell  lysates  were  ana-
lyzed using high-performance liquid chromatogra-
phy (HPLC). Hemoglobin species assay via HPLC 
showed the following: Hb A: 86.8%; Hb A2: 4.7%; Hb 
F: 1.0%. Complete blood count findings were as fol-
lows: Hb: 12.3 g/dL; Hct: 39.0%; MCV: 62.2 fL (low), 
MCH:  19.6  pg  (low);  MCHC:  31.5  g/dL  (low)-red 
blood cell count, white blood cell count, and plate-
let  count  were  as  follows;  5.2  million/mm3, 
6200/mm3,  255000/mm3,  respectively.  Iron  status, 
serum  ferritin,  and  other  hematological  indices 
were normal. DNA was isolated from whole blood 
samples  in  EDTA  using  a  commercially  available 
DNA  extraction  kit  (RTA  Lab,  Ltd.,  Sti,  Turkey). 
Regions of the β-globin gene were sequenced using 
an ABI PRISM BigDye Terminator Cycle Sequencing 
Ready Reaction Kit (Applied Biosystems, Foster City, 
CA., USA), according to the manufacturer's instruc-
tions,  and  the  sequence  reaction  was  analyzed 
using an ABIPRISM 310 genetic analyzer (Applied 
Biosystems, Foster City, California, USA). The muta-
tion was confirmed via sequencing of the anti-sense 
DNA strand, which was performed twice (Figure 1). 
Genetic defects that result in β-thal are primarily 
point mutations, rather than gene deletions or inser-
tions. The mutations result in defects in transcrip-
tion, RNA splicing and modification, translation via 
frameshifts,  and  nonsense  codons  that  produce 
highly unstable β-globin, which cannot be utilized. 
Codon 9/10 (+T) is a rare mutation in the β-globin 
gene and was first described in a Greek family with 
β-thal, and then in an Iranian of Kurdish origin. The 
present  case  had  the  β-thal  trait,  is  the  first  case 
reported  from  Turkey,  and  is  only  the  third  case 
worldwide. The insertion of a thymine nucleotide 
between codons 9 and 10 in exon 1 in the β-globin 
gene causes a reading frameshift from this point, 
leading to an in-frame stop codon at codon 22. The 
insertion of a T nucleotide in exon 1 alters the pro-
tein structure due to a reading frameshift and the 
formation of a stop codon in position 22. The result-
ing  truncated  protein  is  completely  inactivated 
because of the premature termination of translation 
at  codon  22,  instead  of  at  codon  147.  A  similar 
frameshift  mutation  in  the  β-globin  gene  [codon 
9/10 (+G)] was observed in a patient of Turkish ori-
gin by Aulehla-Scholz et al. [8]. Codon 9/10 (+G) 
and codon 9/10 (+T) mutations are similar, but dif-
fer in terms of nucleotide insertion. The presented 
case had thymine insertion between the codon 9 
and codon 10 regions, whereas the case reported 
by  Aulehla-Scholz  et  al.  had  guanine  insertion 
between codon 9 and codon 10. 
β-thal mutations are very heterogeneous and at 
least 40 different mutations are common in Turkey. 
This molecular heterogeneity might be due to the 
historical migration of individuals from non-Medi-
terranean regions to Turkey. β-thal mutations are 
usually population specific and each ethnic group 
has distinct common mutations. Research on dif-
ferent  populations  indicated  that  4-6  mutations 
account for 90%-95% of β-thal chromosomes in any 
given  ethnic  group.  The  prevalence  of  a  limited 
number  of  mutations  in  such  populations  has 
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Figure 1. Sequence Electropherogram Showing a Frameshift Muta-
tion Due to a Thymine Insertion Between Codons 9 and 10 in Exon 
1 of Beta Globin Gene
Thymine insertion
(TCT)
Codon 9
151 153 155 157 159 161 163 165 167
(GCC)
Codon 10
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amplification  or  reverse  dot  blot  hybridization, 
with a set of sequence-specific primers or probes 
for  the  frequently  occurring  β-thal  mutations.  In 
Turkey,  β-thal  mutations  are  very  heterogeneous 
and the above-mentioned techniques are not suf-
ficient for detecting rare or unknown mutations; 
therefore,  direct  DNA  sequence  analysis  of  the 
β-globin gene could prove to be extremely useful 
for  prenatal  diagnosis  and  carrier  identification. 
Detection of rare β-thal mutations may also be use-
ful for establishing a national mutation database 
and in genetic counseling. 
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